Researchers at the Cleveland Clinic have received a $2.5 million grant from the National Institutes of Health to explore deep brain stimulation in post-stroke motor rehabilitation.

About 3 percent of patients undergoing transcatheter aortic valve replacement (TAVR) also have severe mitral stenosis and are at a greater risk of long-term adverse events, researchers reported in JACC: Cardiovascular Interventions.

Santa Clara, Calif. — April 5, 2018 — Cardiva Medical®, an innovator in the field of vascular closure, today announced the company has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication of the VASCADE® Vascular Closure System. Already approved for use in arterial closure, VASCADE is now FDA approved for use in 5-7F femoral venous closures as well.

Speedy follow-up with patients after heart failure hospitalizations doesn’t boost medication adherence long-term, researchers reported April 1 in the Journal of the American Heart Association.

DUBLIN — April 9, 2018 — Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval to begin an investigational device exemption (IDE) pivotal trial to evaluate the Symplicity Spyral(TM) renal denervation system in patients with high blood pressure (hypertension).

People are more likely to prefer a daily cup of tea or a pill over exercise as a treatment options for high blood pressure, according to findings of a survey presented April 7 at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions 2018 in Arlington, Virginia.

Victor Gurewich, MD, has spent more than two decades trying to spread the word about what he sees as an effective, lifesaving treatment approach to heart attack and stroke. At 88 years old, the cardiologist is hoping to breakthrough soon—and a new clinical trial in Europe could help.

Hypertension, elevated cholesterol and hearing difficulty are more prevalent among noise‐exposed workers, according to new research led by the Centers for Disease Control and Prevention (CDC)’s National Institute for Occupational Safety and Health (NIOSH).